L. Heunks (Amsterdam, Netherlands), M. Patout (Paris, France)
Introduction L. Heunks (Amsterdam, Netherlands), M. Patout (Paris, France)
| |
A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS). J. Pottecher (Strasbourg, France), V. Sato (Sau Paulo, Brazil), Y. Plétan (Paris, France), A. Comenducci (Paris, France), V. Desort-Henin (paris, France), M. Jandrot-Perrus (Paris, France), S. Binay (Paris, France), A. Meilhoc (Paris, France), G. Avenard (Paris, France)
| |
Higher versus lower dose corticosteroids for moderate to severe COVID-19: a systematic review, dose response and network meta-analysis. T. Pitre (Hamilton, Canada), J. Mah (Halifax, Canada), W. Helmeczi (Ottawa, Canada), J. Su (Hamilton, Canada), S. Danhoe (Hamilton, Canada), W. Plaxton (Hamilton, Canada), S. Giilck (Hamilton, Canada), D. Zeraatkar (Harvard University, United States)
| |
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study C. Kodde (Berlin, Germany), F. Timmen (Bonn, Germany), S. Hohenstein (Leipzig, Germany), A. Bollmann (Leipzig, Germany), M. Bonsignore (Duisburg, Germany), R. Kuhlen (Berlin, Germany), I. Nachtigall (Berlin, Germany), S. Tasci (Siegburg, Germany)
| |
SUSTAINED ALVEOLAR FIBROPROLIFERATION IN PATIENTS WITH NON-RESOLVING COVID-19 RELATED ARDS DOES NOT LEAD TO PULMONARY FIBROSIS. J. Duitman (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), L. Meijboom (Amsterdam, Netherlands), H. De Vries (Amsterdam, Netherlands), L. Boers (Amsterdam, Netherlands), S. Blok (Amsterdam, Netherlands), A. Saris (Amsterdam, Netherlands), A. Schuurman (Amsterdam, Netherlands), T. Reijnders (Amsterdam, Netherlands), J. Garcia Vallejo (Amsterdam, Netherlands), H. Bontkes (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), A. Vlaar (Amsterdam, Netherlands), W. Wiersinga (Amsterdam, Netherlands), R. Lutter (Amsterdam, Netherlands), T. Van Der Poll (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), L. Heunks (Amsterdam, Netherlands)
| |
Extracorporeal life support allows lung transplant in anti-MDA5+ rapidly progressive-interstitial lung disease. P. Bay (Creteil, France), M. Pineton De Chambrun (Paris, France), A. Roux (Siuresnes, France), V. Bunel (Paris, France), A. Combes (Paris, France), D. Israël Biet (Paris, France), B. Zuber (Paris, France), H. Nunes (Paris, France), Y. Allenbach (Paris, France), Y. Uzunhan (Paris, France)
| |
Recirculation in venovenous extracorporeal membrane oxygenation C. Fisser (Regensburg, Germany), O. Palmer (Stockholm, Sweden), M. Sallisalmi (Stockholm, Sweden), M. Paulus (Regensburg, Germany), M. Foltan (Regensburg, Germany), A. Philipp (Regensburg, Germany), M. Malfertheiner (Regensburg, Germany), M. Lubnow (Regensburg, Germany), T. Müller (Regensburg, Germany), L. Broman (Stockholm, Sweden)
| |
Early prediction of mortality of septic patients visiting emergency room using machine learning J. Heo (Chuncheon-si, Republic of Korea), Y. Heo (Chuncheon-si, Republic of Korea), D. Moon (Chuncheon-si, Republic of Korea), S. Bak (Chuncheon-si, Republic of Korea), W. Kim (Chuncheon-si, Republic of Korea), S. Han (Chuncheon-si, Republic of Korea), S. Choi (Chuncheon-si, Republic of Korea), D. Kim (Chuncheon-si, Republic of Korea), Y. Kim (Chuncheon-si, Republic of Korea), H. Choi (Chuncheon-si, Republic of Korea)
| |
Prognostic value of serum chemerin in critically ill patients with sepsis: a prospective study I. Karampela (Athens, Greece), G. Christodoulatos (Athens, Greece), N. Vallianou (Athens, Greece), D. Tsilingiris (Athens, Greece), E. Chrysanthopoulou (Athens, Greece), G. Skyllas (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Armaganidis (Athens, Greece), M. Dalamaga (Athens, Greece)
| |
Effect of phosphodiesterase inhibitors on lung function, oxidative damage and inflammation in a rabbit model of acute respiratory distress syndrome P. Kosutova (Martin, Slovakia), P. Mikolka (Martin, Slovakia), D. Mokra (Martin, Slovakia), A. Calkovska (Martin, Slovakia)
| |
Late Breaking Abstract - Effect of N-acetyl cysteine in a patient cohort with severe or very severe COVID-19 pneumonia C. Gotera Rivera (Madrid, Spain), C. López Chang (Madrid, Spain), L. De La Dueña (Madrid, Spain), L. Llanos Jiménez (Madrid, Spain), R. Cortés (Madrid, Spain), O. Sánchez Pernaute (Madrid, Spain), C. Pérez Calvo (Madrid, Spain), A. Ioan (Madrid, Spain), J. Pérez (Madrid, Spain), A. Santos Oviedo (Madrid, Spain), S. Heili Frades (Madrid, Spain), A. Naya Prieto (Madrid, Spain), I. Fernández Ormaechea (Madrid, Spain), M. Carballosa De Miguel (Madrid, Spain), M. Rodríguez Nieto (Madrid, Spain), G. Peces Barba (Madrid, Spain)
| |
Discussion
| |